ClassID:

95252

C07D403/12 - CPC Classification

Classification description:

Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links

Recent Application in this class:
#1
20260138971
2026-05-21

PROCESS FOR SYNTHESIS OF RES METIROM AND ITS INTERMEDIATES THEREOF

#2
20260138966
2026-05-21

WNT SIGNALING PATHWAY INHIBITORS FOR TREATMENTS OF DISEASE

#3
20260138959
2026-05-21

QUINAZOLINE DERIVATIVE COMPOUND AND USE THEREOF

#4
20260137684
2026-05-21

ROCK2 Inhibitors And Uses Thereof

#5
20260132158
2026-05-14

PHENYL OXY AMIDE KINASE INHIBITORS

#6
20260132147
2026-05-14

BAX INHIBITORS AND USES THEREOF

#7
20260132140
2026-05-14

IMIDAZOLYL-AMINO-PYRAZINE-CARBONITRILS AS CHK-1 INHIBITORS

#8
20260132139
2026-05-14

HIV INHIBITOR COMPOUNDS

#9
20260132132
2026-05-14

3A,4,5,6-TETRAHYDRO-1 H-PYRAZOLO[3,4-C]PYRIDIN-7(7AH)-ONE DERIVATIVES AS FACTOR XIIA INHIBITORS

#10
20260132126
2026-05-14

IMIDAZOLE DERIVATIVES

#11
20260132123
2026-05-14

ABAD INHIBITOR COMPOUNDS

#12
20260132121
2026-05-14

INHIBITORS OF RIPK2 AND MEDICAL USES THEREOF

#13
20260132119
2026-05-14

Alkylphenyl Substituted Compounds, Compositions and Methods of Use

#14
20260132113
2026-05-14

Amino Pyrimidine Derivatives

#15
20260132111
2026-05-14

Host-Targeted Pan-Respiratory Antiviral Small Molecule Therapeutics

#16
20260132109
2026-05-14

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY

#17
20260125367
2026-05-07

CANCER TREATMENTS TARGETING CANCER STEM CELLS

#18
20260125366
2026-05-07

METHODS FOR TREATING CANCER

#19
20260125364
2026-05-07

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

#20
20260125361
2026-05-07

TYK2 INHIBITORS AND USES THEREOF

#21
20260115139
2026-04-30

Amino Acid-Containing Ionizable Lipids for the Delivery of Therapeutic Agents

#22
20260109709
2026-04-23

2-AMINO IMIDAZOLE DERIVATIVES AS PRMT5 INHIBITORS

#23
20260109697
2026-04-23

4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES

#24
20260109696
2026-04-23

SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS

#25
20260109690
2026-04-23

HDAC6 INHIBITORS AND METHOD OF THEIR USE

#26
20260109686
2026-04-23

PYRIDAZIN-3(2H)-ONE AND PYRIDIN-2(1H)-ONE PARP INHIBITOR COMPOUNDS

#27
20260109677
2026-04-23

COMPOUNDS, DEVICES, AND USES THEREOF

#28
20260109672
2026-04-23

SARS-COV-2 MPRO INHIBITORS AND USES THEREOF

#29
20260103455
2026-04-16

ULK3 INHIBITORS AND USES THEREOF

#30
20260102406
2026-04-16

SUBSTITUTED QUINAZOLINES FOR INHIBITING KINASE ACTIVITY

#31
20260098032
2026-04-09

METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION

#32
20260098030
2026-04-09

NEGATIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2

#33
20260098019
2026-04-09

SYNTHESIS OF NSAID CONJUGATES AS ANTI-INFLAMMATORY AGENTS USING THE MOLECULAR HYBRIDIZATION

#34
20260098017
2026-04-09

NOVEL AROMATIC RING DERIVATIVE CONTAINING AMIDE SUBSTITUTION AND USE THEREOF

#35
20260097047
2026-04-09

Small molecule inhibitors of the ribosome biogenesis factor NVL2

#36
20260092038
2026-04-02

CANNABINOID RECEPTOR 1 ANTAGONISTS/INVERSE AGONISTS AND USES THEREOF

#37
20260085082
2026-03-26

KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE

#38
20260085073
2026-03-26

PYRAZOLYLCARBOXAMIDE COMPOUNDS AND THEIR USE IN THERAPY

#39
20260085062
2026-03-26

NOVEL COMPOUNDS AS CK2 INHIBITORS

#40
20260085050
2026-03-26

TRIPLE KINASE INHIBITORS

#41
20260085048
2026-03-26

ACSS2 INHIBITORS AND METHODS OF USE THEREOF

#42
20260085040
2026-03-26

AMINO ACID AND CARBOHYDRATE PSILOCIN DERIVATIVES

#43
20260078130
2026-03-19

NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF

#44
20260078105
2026-03-19

Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors

#45
20260078095
2026-03-19

NEUROTENSIN RECEPTOR LIGANDS

#46
20260078094
2026-03-19

ANTI-VIRAL COMPOUNDS

#47
20260076975
2026-03-19

TPK AGONIST AND METHOD FOR USING SAME TO TREAT NEURODEGENERATIVE DISEASES

#48
20260076962
2026-03-19

LANTHIONINE SYNTHETASE C-LIKE 2-BASED THERAPEUTICS

#49
20260070894
2026-03-12

COMPOUNDS FOR USE IN SYNTHESIS OF PEPTIDOMIMETICS

#50
20260070886
2026-03-12

QUINOLINE PIPERAZINE DERIVATIVES, PHARMACEUTICAL COMPOSITION AND USES THEREOF

#51
20260070878
2026-03-12

TNKS2 INHIBITORS

#52
20260069571
2026-03-12

DDR1 AND DDR2 INHIBITORS FOR THE TREATEMENT OF CANCER AND FIBROTIC DISEASES

#53
20260062402
2026-03-05

KCC2 POTENTIATORS AND USES THEREOF

#54
20260062391
2026-03-05

HYDRAZIDE CONTAINING NUCLEAR TRANSPORT MODULATORS AND USES THEREOF

#55
20260060926
2026-03-05

NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME

#56
20260055117
2026-02-26

SUBSTITUTED PYRIDONE GPR84 ANTAGONISTS AND USES THEREOF

#57
20260055087
2026-02-26

INHIBITORS OF LRRK2 KINASE

#58
20260055084
2026-02-26

INHIBITORS OF RAF KINASES

#59
20260055083
2026-02-26

APOL1 INHIBITORS AND METHODS OF USE

#60
20260055079
2026-02-26

PHTHALAZINONE COMPOUNDS AS PARP7 INHIBITORS

#61
20260049092
2026-02-19

ANTIBACTERIAL COMPOUNDS

#62
20260049078
2026-02-19

DIFLUORO- AND TRIFLUORO-ACETYL HYDRAZIDES AS SELECTIVE HDAC6 INHIBITORS

#63
20260049071
2026-02-19

PROTEIN TYROSINE KINASE INHIBITOR AND MEDICAL USE THEREOF

#64
20260049068
2026-02-19

Substituted Tetrazolyl Compounds Useful as T Cell Activators

#65
20260049061
2026-02-19

SMALL MOLECULES AS KCNQ2/3 (KV7.2/3) CHANNEL ACTIVATORS AND THEIR MEDICAL USE THEREOF

#66
20260048060
2026-02-19

POLYCYCLIC THYROID HORMONE b RECEPTOR AGONIST AND USE THEREOF

#67
20260042748
2026-02-12

AZETIDINE COMPOUNDS FOR TREATMENT OF HSV

#68
20260042747
2026-02-12

KIT INHIBITORS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF

#69
20260035360
2026-02-05

INHIBITORS OF MYC AND USES THEREOF

#70
20260035352
2026-02-05

Inhibitors of Platelet Function and Methods for Use of the Same

#71
20260034140
2026-02-05

MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE

#72
20260034138
2026-02-05

NOVEL PYRIMIDINYL AND TRIAZINYL SULFONAMIDE DERIVATIVES

#73
20260034127
2026-02-05

TREATMENT OF GVHD

#74
20260028316
2026-01-29

Biphenyl and Phenylpyridine Compounds

#75
20260027113
2026-01-29

PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE

#76
20260022110
2026-01-22

DIARYLACETYLENE COMPOUND, PREPARATION METHOD THEREOF, AND USES THEREOF

#77
20260015339
2026-01-15

CALIX[4]ARENES WITH HIGH ANTICANCER ACTIVITY

#78
20260015337
2026-01-15

COMPOUNDS FOR TREATMENT A CORONAVIRUS INFECTION

#79
20260015328
2026-01-15

ATM KINASE INHIBITORS

#80
20260015321
2026-01-15

CHEMICAL COMPOUNDS AND USES THEREOF

#81
20260008772
2026-01-08

2-Indolone Derivatives and Use Thereof

#82
20260008771
2026-01-08

PYRIDAZINE BASED SMALL MOLECULE INHIBITOR OF COGNITIVE IMPAIRMENT

#83
20260007782
2026-01-08

PREPARATION METHOD FOR LIQUID COMPOSITION COMPRISING COMPOUND I AND USE IN MYOCARDIAL PERFUSION PET IMAGING

#84
20260007668
2026-01-08

AMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF

#85
20260001873
2026-01-01

NOVEL INHIBITORS

#86
20260001871
2026-01-01

TRIAZOLE DERIVATIVES AS MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR D

#87
20260001867
2026-01-01

THR BETA RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD AND USE THEREOF

#88
20260001840
2026-01-01

Functionalized Conjugation Crosslinkers and Uses Thereof

#89
20250388601
2025-12-25

Compounds, Compositions and Methods

#90
20250388595
2025-12-25

MODULATORS OF EUKARYOTIC INITIATION FACTOR 2B, COMPOSITIONS AND METHODS

#91
20250388571
2025-12-25

AMP-ACTIVATED PROTEIN KINASE MODULATOR COMPOUNDS AND USES THEREOF

#92
20250388554
2025-12-25

ANTIBACTERIAL COMPOUNDS, METHOD OF PRODUCTION AND USE THEREOF

#93
20250388553
2025-12-25

AMINOPYRAZINE DERIVATIVES AS PI3K-y INHIBITORS

#94
20250388551
2025-12-25

COMPOUNDS INDUCING PRODUCTION OF PROTEINS BY IMMUNE CELLS

#95
20250388536
2025-12-25

3-ALKYNYL CARBOXAMIDES AS AEP MODULATORS

#96
20250382280
2025-12-18

PYRAZOLE DERIVATIVES FOR THE INHIBITION OF PHAGOCYTOSIS

#97
20250376464
2025-12-11

Compounds for treatment a coronavirus infection

#98
20250376461
2025-12-11

INDAZOLE DERIVATIVES FOR TREATING TRPM3-MEDIATED DISORDERS

#99
20250376443
2025-12-11

MASP-2 INHIBITORS AND METHODS OF USE

#100
20250368627
2025-12-04

PYRAZOLESULFONAMIDES AS ANTITUMOR AGENTS

#101
20250368626
2025-12-04

SOLID FORMS OF 2-(3,5-DICHLORO-4-((5-ISOPROPYL-6-OXO-1,6-DIHYDROPYRIDAZIN-3-YL)OXY)PHENYL)-3,5-DIOXO-2,3,4,5-TETRAHYDRO-1,2,4-TRIAZINE-6-CARBONITRILE

#102
20250368625
2025-12-04

PIPERAZINES

#103
20250368624
2025-12-04

M24B AMINOPEPTIDASE INHIBITORS FOR CARD8 INFLAMMASOME ACTIVATION

#104
20250368608
2025-12-04

SELECTIVE HDAC6 INHIBITOR

#105
20250368605
2025-12-04

Novel Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds, Processes for their Preparation and Therapeutic Uses Thereof

#106
20250368604
2025-12-04

MASP-2 INHIBITORS AND METHODS OF USE

#107
20250361238
2025-11-27

1,4-DIPHENYL-1H-INDAZOLE AND 1-PYRIDIN-2-YL-4-PHENYL-1H-INDAZOLE DERIVATIVES AS PD-1/PD-L1 MODULATORS FOR THE TREATMENT OF CANCER

#108
20250361213
2025-11-27

1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF

#109
20250353833
2025-11-20

DPP9 BINDING COMPOUNDS

#110
20250353832
2025-11-20

PROCESS FOR THE PREPARATION OF AMINOPYRIDAZINE DERIVATIVES

#111
20250353817
2025-11-20

INTERLUKIN-17A INHIBITORS AND USES THEREOF

#112
20250346943
2025-11-13

DEGRADER COMPOUNDS OF QSOX1 mRNA

#113
20250346587
2025-11-13

NITROGEN-CONTAINING FIVE-MEMBERED HETEROCYCLIC DERIVATIVES AS CHECKPOINT KINASE 1 INHIBITOR AND USES THEREOF

#114
20250346582
2025-11-13

SPLEEN TYROSINE KINASE INHIBITORS AND METHODS OF USE THEREOF

#115
20250346580
2025-11-13

NOVEL PYRIMIDINYL SULFONAMIDE DERIVATIVES

#116
20250346578
2025-11-13

BIS(DIAZIRINE) DERIVATIVES AS PHOTO-CROSSSLINKER FOR TREATING CORNEAL ECTATIC DISORDERS

#117
20250345344
2025-11-13

NOVEL NRF2 ACTIVATOR AND USE THEREOF

#118
20250340557
2025-11-06

PYRIMIDINE DERIVATIVE

#119
20250340542
2025-11-06

THYROID HORMONE RECEPTOR AGONISTS

#120
20250340541
2025-11-06

METHODS OF PREPARING MODULATORS OF THR-BETA

#121
20250340540
2025-11-06

Crystal Forms Of HS378 And Preparation Method Therefor

#122
20250333423
2025-10-30

SMALL MOLECULE MODULATORS OF GP130 SIGNALING PATHWAYS

#123
20250333411
2025-10-30

COMPOUNDS AND METHODS FOR INHIBITING FASCIN

#124
20250333396
2025-10-30

INHIBITING ATAXIA TELANGIECTASIA AND RAD3-RELATED PROTEIN (ATR)

#125
20250326741
2025-10-23

GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR ANTAGONISTS AND USES THEREOF

#126
20250326738
2025-10-23

MALT1 Modulators and Uses Thereof

#127
20250326718
2025-10-23

4-PHENYL-2-PYRROLIDINONES AND METHODS OF USING THEREOF

#128
20250326713
2025-10-23

INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

#129
20250325547
2025-10-23

ANTI-SARS-COV-2 DRUG

#130
20250320197
2025-10-16

THYROID HORMONE RECEPTOR AGONISTS AND USE THEREOF

#131
20250320196
2025-10-16

APOL1 INHIBITORS AND METHODS OF USES THEREOF

#132
20250320185
2025-10-16

AMINOHETEROARYL KINASE INHIBITORS

#133
20250313551
2025-10-09

PROCESS FOR THE PREPARATION OF A QUINAZOLINONE DERIVATIVE

#134
20250313544
2025-10-09

INHIBITORS OF GLUTATHIONE S-TRANSFERASE ZETA 1 (GSTZ1) AND METHODS OF USE

#135
20250313535
2025-10-09

ALPHA 4 BETA 7 INTEGRIN MODULATORS AND USES THEREOF

#136
20250312362
2025-10-09

INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

#137
20250312352
2025-10-09

GLP-1R MODULATING COMPOUNDS

#138
20250311727
2025-10-09

SUBSTITUTED 2-AMINOAZINES AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES

#139
20250304571
2025-10-02

BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF

#140
20250304561
2025-10-02

MODULATORS OF THR-BETA AND METHODS OF USE THEREOF

#141
20250304560
2025-10-02

MODULATORS OF NLRP3 INFLAMMASOME AND RELATED PRODUCTS AND METHODS

#142
20250304559
2025-10-02

Ether-Linked Antiviral Compounds

#143
20250296935
2025-09-25

Diamine Derivatives as Inhibitors of Leukotriene A4 Hydrolase

#144
20250296926
2025-09-25

SELECTIVE LIGANDS FOR MODULATION OF GIRK CHANNELS

#145
20250296922
2025-09-25

POLYSUBSTITUTED PYRROLIDINE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF

#146
20250296916
2025-09-25

BICYCLIC PIPERAZINONES AND THERAPEUTIC USES THEREOF

#147
20250289789
2025-09-18

REVERSIBLE LYSINE COVALENT MODIFIERS OF CDK2 AND USES THEREOF

#148
20250282783
2025-09-11

PROTEIN STABILIZING COMPOUNDS CONTAINING USP28 AND/OR USP25 TARGETING LIGANDS

#149
20250282761
2025-09-11

SALT AND CRYSTAL FORMS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR

#150
20250282760
2025-09-11

OREXIN RECEPTOR AGONISTS

#151
20250282736
2025-09-11

SMALL MOLECULE MODULATORS OF HUMAN PREGNANE X RECEPTOR

#152
20250276955
2025-09-04

CORONAVIRUS MAIN PROTEASE INHIBITORS AND METHODS USING SAME

#153
20250270238
2025-08-28

A NEW BIFUNCTIONAL LINCHPIN THAT REACTS SELECTIVELY WITH CYSTEINE RESIDUES TO INVOKE CYCLIZATION WHILE CONCURRENTLY INTRODUCING A DOTAGA MOIETY FOR RADIOMETAL CHELATION

#154
20250270194
2025-08-28

PYRAZOLE-SUBSTITUTED CYCLOPENTANOL ESTER DERIVATIVE AND USE THEREOF

#155
20250270188
2025-08-28

NLRP3 INFLAMMASOME INHIBITORS

#156
20250270172
2025-08-28

Pyrimidine Derivatives As Modulators of the 5-HT2A Serotonin Receptor Useful For The Treatment of Disorders Related Thereto

#157
20250270171
2025-08-28

HUMAN PLASMA KALLIKREIN INHIBITORS

#158
20250270165
2025-08-28

COMPOSITIONS FOR AND METHODS OF MODULATING RNA STABILITY

#159
20250263401
2025-08-21

COMPOUNDS USEFUL FOR TREATING GASTROINTESTINAL TRACT DISORDERS

#160
20250263400
2025-08-21

GCN2 MODULATOR COMPOUNDS

#161
20250263399
2025-08-21

CBL-B MODULATORS AND USES THEREOF

#162
20250263393
2025-08-21

FAP INHIBITORS

#163
20250257041
2025-08-14

INDUCERS OF INTEGRATED STRESS RESPONSE TO TREAT CANCER

#164
20250257040
2025-08-14

HUMAN PLASMA KALLIKREIN INHIBITORS

#165
20250250259
2025-08-07

METHODS FOR TREATING CANCER

#166
20250250258
2025-08-07

CRYSTAL FORM OF FGFR4 SELECTIVE INHIBITOR COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF

#167
20250250237
2025-08-07

ALKYLAMINE OR HETEROALKYLAMINE DERIVATIVES AS INHIBITORS OF NITRIC OXIDE SYNTHASES (NOS), PHARMACEUTICAL PRODUCTS THEREOF, AND METHODS THEREOF

#168
20250250235
2025-08-07

RAF KINASE INHIBITORS AND METHODS OF USE THEREOF

#169
20250250232
2025-08-07

AZETIDINE DERIVATIVES AND USE THEREOF AS DIPEPTIDYL PEPTIDASE 1 INHIBITORS

#170
20250249483
2025-08-07

METHOD AND APPARATUS FOR SORTING HETEROGENEOUS MATERIAL

#171
20250248973
2025-08-07

CANNABINOID RECEPTOR 1 ANTAGONISTS/INVERSE AGONISTS AND USES THEREOF

#172
20250243198
2025-07-31

MASP-2 INHIBITORS AND METHODS OF USE

#173
20250243193
2025-07-31

AMIDE-SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES

#174
20250243187
2025-07-31

ANTI-VIRAL COMPOUNDS

#175
20250243168
2025-07-31

ACETYL-COA SYNTHETASE 2 (ACSS2) INHIBITORS AND METHODS USING SAME

#176
20250243161
2025-07-31

DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS

#177
20250241915
2025-07-31

COMPOUNDS FOR THE TREATMENT OF BRAF-ASSOCIATED DISEASES AND DISORDERS

#178
20250241890
2025-07-31

1,4-DIUREAS AND 1,4-DITHIOUREAS AND USES THEREOF

#179
20250236593
2025-07-24

SMALL MOLECULES THAT SENSITIZE HIV-1 INFECTED CELLS TO ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY

#180
20250235454
2025-07-24

XOPHOS INHIBITORS FOR USE IN THE TREATMENT OF B-CELL LYMPHOMA

#181
20250232847
2025-07-17

WORKFLOW FOR GENERATING COMPOUNDS WITH BIOLOGICAL ACTIVITY AGAINST A SPECIFIC BIOLOGICAL TARGET

#182
20250230144
2025-07-17

QUINAZOLINES AS POTASSIUM ION CHANNEL INHIBITORS

#183
20250230125
2025-07-17

Small Molecule Allosteric Modulators of Serotonin (5-HT) 5-HT2C and 5-HT2A Receptors

#184
20250228851
2025-07-17

ALLOSTERIC INHIBITOR COMPOUNDS FOR OVERCOMING CANCER RESISTANCE

#185
20250223279
2025-07-10

PROCESS FOR THE PREPARATION OF BELUMOSUDIL MESYLATE AND ITS CRYSTALLINE FORM

#186
20250223267
2025-07-10

CYCLOOLEFIN SUBSTITUTED HETEROAROMATIC COMPOUNDS AND THEIR USE

#187
20250223262
2025-07-10

SYNTHESIS OF MORPHINANS WITH REDUCED HERG ACTIVITY AND MOP BINDING

#188
20250221411
2025-07-10

SUBSTITUTED BENZAMIDES AS HERBICIDES

#189
20250216300
2025-07-03

REVERSIBLE FIXING REAGENTS AND METHODS OF USE THEREOF

#190
20250215008
2025-07-03

PREPARATION AND USE OF QUINAZOLINONE DERIVATIVE AS KINASE INHIBITOR

#191
20250214987
2025-07-03

THIOBENZIMIDAZOLE DERIVATIVE PREPARATION METHOD AND NOVEL INTERMEDIATE THEREFOR

#192
20250214971
2025-07-03

QUATERNARY INDAZOLE GLUCOCORTICOID RECEPTOR ANTAGONISTS

#193
20250214964
2025-07-03

COMPOUNDS DERIVED FROM 4-AMINO-N-(4-AMINOPHENYL) BENZAMIDE AND ANALOGUES AND USE THEREOF

#194
20250214963
2025-07-03

SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH

#195
20250214947
2025-07-03

3,4-DIHYDROQUINOXALINE-2-CARBOXIMIDE DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR PREVENTING OR TREATING CANCER DISEASE

#196
20250214945
2025-07-03

THIOBENZIMIDAZOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND USE THEREOF

#197
20250214942
2025-07-03

INHIBITORS OF RECEPTOR INTERACTING PROTEIN KINASE I FOR THE TREATMENT OF DISEASE

#198
20250214932
2025-07-03

T-TYPE CALCIUM CHANNEL MODULATORS COMPRISING AN AZASPIRONONANE CORE AND METHODS OF USE THEREOF

#199
20250213586
2025-07-03

STAT6 INHIBITORS AND USES THEREOF

#200
20250206729
2025-06-26

DUAL RAF AND TUBULIN INHIBITORS AND METHODS OF USE THEREOF

#201
20250206725
2025-06-26

MODULATORS OF THR-BETA AND METHODS OF USE THEREOF

#202
20250206724
2025-06-26

SUBSTITUTED 3-AMINO INDAZOLE DERIVATIVES AS KINASE INHIBITORS

#203
20250206722
2025-06-26

SMALL MOLECULE INHIBITORS OF TEA DOMAIN FAMILY MEMBERS

#204
20250206721
2025-06-26

Prostaglandin Receptor EP2 Antagonists, Derivatives, and Uses Related Thereto

#205
20250205232
2025-06-26

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

#206
20250205167
2025-06-26

NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME

#207
20250197377
2025-06-19

NOVEL PHARMACEUTICAL SALTS AND POLYMORPHIC FORMS OF AN ERBB AND BTK INHIBITOR

#208
20250197360
2025-06-19

NOVEL DIAZEPINES THAT TARGET YELLOW FEVER VIRUS NON-STRUCTURAL 4B (NS4B) PROTEIN AND THEIR METHOD OF USE

#209
20250195646
2025-06-19

COMBINATIONS AND USES THEREOF

#210
20250195475
2025-06-19

CDK2 INHIBITOR AND PREPARATION METHOD AND USE THEREOF

#211
20250188061
2025-06-12

NOVEL DEUTERATED PYRIMIDIN-2-YL SULFONAMIDE DERIVATIVES

#212
20250188057
2025-06-12

NON-AROMATIC CYCLIC-PYRIMIDINE ANALOGS AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

#213
20250188041
2025-06-12

NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA

#214
20250188039
2025-06-12

HYDANTOIN CONTAINING DEOXYURIDINE TRIPHOSPHATASE INHIBITORS

#215
20250188035
2025-06-12

TUBULIN INHIBITORS

#216
20250188030
2025-06-12

Biphenyl and Phenylpyridine Compounds

#217
20250179061
2025-06-05

RIP1 MODULATORS, PREPARATIONS, AND USES THEREOF

#218
20250179054
2025-06-05

THRB RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD AND USE THEREOF

#219
20250179053
2025-06-05

THRB RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD AND USE THEREOF

#220
20250179052
2025-06-05

PYRIMIDINYL-OXY-QUINOLINE BASED HERBICIDAL COMPOUNDS

#221
20250179051
2025-06-05

PYRIMIDINLY-OXY-QUINOLINE BASED HERBICIDAL COMPOUNDS

#222
20250179050
2025-06-05

POLYMORPH AS THYROID HORMONE RECEPTOR AGONISTS AND USE THEREOF

#223
20250179033
2025-06-05

NEW ANTIVIRAL TRIAZOLE DERIVATIVES, THEIR SYNTHESIS AND THEIR USE FOR TREATMENT OF MAMMALIAN VIRAL INFECTIONS

#224
20250177383
2025-06-05

DI-CYCLOPROPYL BASED IL-17A MODULATORS AND USES THEREOF

#225
20250171462
2025-05-29

COMPOUNDS, COMPOSITIONS, AND METHODS

#226
20250171453
2025-05-29

HETEROCYCLIC COMPOUNDS AND USES THEREOF

#227
20250171431
2025-05-29

HETEROCYCLIC INHIBITORS OF IGF-1R FOR TREATMENT OF DISEASE

#228
20250171416
2025-05-29

NOVEL PYRIMIDINE-2,4-DIAMINE DERIVATIVES, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER

#229
20250171399
2025-05-29

PYRROLIDINE COMPOUNDS

#230
20250170283
2025-05-29

COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS

#231
20250170136
2025-05-29

1,2,4-TRIAZIN-3(2H)-ONE COMPOUNDS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES

#232
20250170130
2025-05-29

MODULATORS OF MYC FAMILY PROTO-ONCOGENE PROTEIN

#233
20250170120
2025-05-29

ALLOSTERIC STING MODULATORS AND METHODS OF USE

#234
20250163032
2025-05-22

NOVEL MOLECULES AS INHIBITORS OF DNA DAMAGE REPAIR PATHWAY

#235
20250163030
2025-05-22

PYRIDIZIN-3(2H)-ONE DERIVATIVES

#236
20250163029
2025-05-22

PYRIDONE OR PYRIMIDONE DERIVATIVE AND APPLICATION THEREOF

#237
20250163027
2025-05-22

GPR88-RECEPTOR-AGONIST

#238
20250163026
2025-05-22

Deuterium-Enriched Nirmatrelvir as SARS-CoV-2 Mpro Inhibitor for the Treatment of COVID-19

#239
20250163006
2025-05-22

New Coolants, and Preparations Containing Same

#240
20250154169
2025-05-15

COMPOUNDS AND METHODS FOR MODULATING SPLICING

#241
20250154138
2025-05-15

Small Molecule IL-17A Modulators

#242
20250154134
2025-05-15

COMPOUND AS FAK INHIBITOR AND USE THEREOF

#243
20250154132
2025-05-15

CRYSTAL FORM OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE

#244
20250154131
2025-05-15

PYRROLIDINE ANTIVIRAL COMPOUND

#245
20250154130
2025-05-15

NOVEL THR BETA ANALOGS AND USES THEREOF

#246
20250154114
2025-05-15

MATERIAL FOR METAL PATTERNING, HETEROCYCLIC COMPOUND, THIN FILM FOR METAL PATTERNING, ORGANIC ELECTROLUMINESCENT DEVICE, ELECTRONIC DEVICE, AND METHOD FOR FORMING METAL PATTERN

#247
20250154112
2025-05-15

A PREPARATION OF QUINAZOLINEDIONES AND USE THEREOF

#248
20250154111
2025-05-15

1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF

#249
20250152588
2025-05-15

HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS

#250
20250152584
2025-05-15

NLRP3 INFLAMMASOME INHIBITOR AND USES THEREOF

#251
20250145598
2025-05-08

ACID CERAMIDASE INHIBITORS AND USES THEREOF

#252
20250145592
2025-05-08

COMPOUNDS, COMPOSITIONS, AND METHODS

#253
20250145586
2025-05-08

KINASE INHIBITORS FOR THE TREATMENT OF CENTRAL AND PERIPHERAL NERVOUS SYSTEM DISORDERS

#254
20250145575
2025-05-08

MACROMOLECULE-SUPPORTED 8-SULFONYL-BENZAZEPINE COMPOUNDS AND THEIR USES

#255
20250136619
2025-05-01

HETEROBIFUNCTIONAL COMPOUNDS AND THEIR USE IN TREATING DISEASE

#256
20250136595
2025-05-01

ACYLATED HETEROCYCLIC QUINAZOLINE DERIVATIVES AS INHIBITORS OF ERBB2

#257
20250136590
2025-05-01

SUBSTITUTED BENZYL-TRIAZOLE COMPOUNDS FOR CBL-B INHIBITION, AND FURTHER USES THEREOF

#258
20250136581
2025-05-01

SUBSTITUTED TRIAZOLE DERIVATIVE, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF

#259
20250136580
2025-05-01

INDOLINONE DERIVATIVES AS INHIBITORS OF MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE

#260
20250135024
2025-05-01

Drug-Conjugates, Conjugation Methods, And Uses Thereof

#261
20250129070
2025-04-24

BIFUNCTIONAL ANDROGEN RECEPTOR COMPOUNDS

#262
20250129044
2025-04-24

PYRIDINYL DERIVATIVES AS SODIUM CHANNEL ACTIVATORS

#263
20250129021
2025-04-24

SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS

#264
20250129020
2025-04-24

MASP-2 INHIBITORS AND METHODS OF USE

#265
20250127800
2025-04-24

PYRIMIDINE OR PYRIDINE DERIVATIVE AND MEDICINAL USE THEREOF

#266
20250122192
2025-04-17

5-PYRIMIDINECARBOXAMIDE DERIVATIVES AND METHODS OF USING THE SAME

#267
20250122153
2025-04-17

Protease Inhibitors as Antivirals

#268
20250115604
2025-04-10

SULFOXIMINE GLYCOSIDASE INHIBITORS

#269
20250115597
2025-04-10

TYK2 INHIBITORS AND COMPOSITIONS AND METHODS THEREOF

#270
20250115586
2025-04-10

BENZAMIDES OF PYRAZOLYLAMINO- PYRIMIDINYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF

#271
20250115585
2025-04-10

METHOD FOR PRODUCING DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE

#272
20250115561
2025-04-10

BIPHENYL-SUBSTITUTED EPITHELIAL SODIUM CHANNEL BLOCKING COMPOUNDS

#273
20250115559
2025-04-10

PREPARATION METHOD OF PYRIDAZINONE DERIVATIVE, AND INTERMEDIATE THEREOF

#274
20250115554
2025-04-10

NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT AND ELECTRONIC DEVICE

#275
20250115546
2025-04-10

LINKERS FOR ANTIBODY DRUG CONJUGATES

#276
20250109110
2025-04-03

BICYCLIC-SUBSTITUTED EPITHELIAL SODIUM CHANNEL BLOCKING COMPOUNDS

#277
20250101010
2025-03-27

SELECTIVE ANGIOTENSIN II COMPOUNDS

#278
20250101005
2025-03-27

ADDITIVE FOR IMPARTING ULTRAVIOLET ABSORBENCY AND/OR HIGH REFRACTIVE INDEX TO MATRIX, AND RESIN MEMBER USING SAME

#279
20250101004
2025-03-27

NOVEL KALIRIN INHIBITORS FOR REGULATION OF SYNAPTIC PLASTICITY AND NEUROPATHIC PAIN TREATMENT

#280
20250101003
2025-03-27

SPIROCYCLIC CAV2.3 ANTAGONISTS

#281
20250101002
2025-03-27

DEUTERATED INFIGRATINIB COMPOUNDS

#282
20250100977
2025-03-27

MERCAPTOPYRIMIDINE COMPOUNDS THAT INHIBIT NONHOMOLOGOUS END JOINING AND METHODS THEREOF

#283
20250100966
2025-03-27

MEK INHIBITORS AND METHODS OF THEIR USE

#284
20250099424
2025-03-27

Nitrile-Containing Antiviral Compounds

#285
20250098525
2025-03-20

COMPOUND AND USE THEREOF IN ORGANIC OPTOELECTRONIC DEVICE

#286
20250092028
2025-03-20

BENZIMIDAZOLE DERIVATIVES AS ERBB TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER

#287
20250092027
2025-03-20

ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICANCER ACTIVITY

#288
20250092020
2025-03-20

IDO/TDO Inhibitor

#289
20250092014
2025-03-20

COMPOUNDS AND METHODS OF ACTIVATING LIPOPROTEIN LIPASE

#290
20250091994
2025-03-20

RAS/RAF BINDING INHIBITOR COMPOUND

#291
20250091989
2025-03-20

SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS

#292
20250084067
2025-03-13

PYRAZOLE-SUBSTITUTED CYCLOPENTANOL ESTER DERIVATIVE AND USE THEREOF

#293
20250084040
2025-03-13

SUBSTITUTED HETEROCYCLES AS c-MYC TARGETING AGENTS

#294
20250082609
2025-03-13

HETEROCYCLIC SULFONAMIDE DERIVATIVES AND PHARMACEUTICAL USES THEREOF

#295
20250074898
2025-03-06

SOLID FORMS OF 2-(3,5-DICHLORO-4-((5-ISOPROPYL-6-OXO-1,6-DIHYDROPYRIDAZIN-3-YL)OXY)PHENYL)-3,5-DIOXO-2,3,4,5-TETRAHYDRO-1,2,4-TRIAZINE-6-CARBONITRILE

#296
20250074897
2025-03-06

PYRIDAZINONES AS PARP7 INHIBITORS

#297
20250074896
2025-03-06

ARYLTETRAHYDROPYRIDAZINE DERIVATIVE OR SALT THEREOF AND INSECTICIDAL AGENT CONTAINING THE COMPOUND AND METHOD FOR USING SAME

#298
20250074895
2025-03-06

CDK2 INHIBITORS AND METHODS OF MAKING AND USING SAME

#299
20250074888
2025-03-06

PYRIDAZINE DERIVATIVES AS MODULATORS OF NLRP3 INFLAMMASOME AND RELATED METHODS

#300
20250074874
2025-03-06

SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS